Table 2.
HR [95% CI] | P value | |
---|---|---|
Baseline characteristics | ||
Age | 1.048 [1.039–1.057] | <0.0001* |
Men | 1.048 [0.866–1.273] | 0.6289 |
CKD | 1.814 [1.475–2.248] | <0.0001* |
Ischaemic aetiology | 1.550 [1.278–1.874] | <0.0001* |
Laboratory findings at admission | ||
Haemoglobin | 0.858 [0.822–0.896] | <0.0001* |
Creatinine | 1.112 [1.055–1.160] | 0.0004* |
BUN | 1.032 [1.027–1.036] | <0.0001* |
BUN/creatinine ratio | 1.024 [1.016–1.030] | <0.0001* |
Vital signs, echocardiographic and laboratory findings, medications at discharge | ||
Systolic BP | 0.991 [0.986–0.997] | 0.0028* |
Resting HR | 1.010 [1.002–1.017] | 0.0067* |
WRF (ΔCr > 0.3) | 1.434 [1.091–1.853] | 0.0105* |
LVEF | 0.990 [0.984–0.996] | 0.0020* |
Haemoglobin | 0.804 [0.768–0.843] | <0.0001* |
Creatinine | 1.164 [1.086–1.232] | 0.0001* |
BUN | 1.019 [1.016–1.022] | <0.0001* |
BUN/creatinine ratio | 1.016 [1.009–1.021] | <0.0001* |
ACE‐I or ARBs | 0.603 [0.500–0.730] | <0.0001* |
Loop diuretics | 1.455 [1.147–1.871] | 0.0017* |
Beta‐blockers | 0.759 [0.616–0.943] | 0.0133* |
ACE‐I, angiotensin‐converting enzyme inhibitor; ARBs, angiotensin receptor blockers; BP, blood pressure; BUN, blood urea nitrogen; CI, confidence interval; CKD, chronic kidney disease; Cr, creatinine; HR, hazard ratio; HR, heart rate; LVEF, left ventricular ejection fraction; WRF, worsening renal function.
P < 0.05.